Loading...
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
Although CAR T-cell therapy has demonstrated tremendous clinical efficacy especially in hematological malignancies, severe treatment-associated toxicities still compromise the widespread application of this innovative technology. Therefore, developing novel approaches to abrogate CAR T-cell-mediated...
Na minha lista:
| Udgivet i: | Cancer Immunol Immunother |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6768917/ https://ncbi.nlm.nih.gov/pubmed/31414180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02376-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|